Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment.
Lidia Maria Rebolho Batista ArantesRenato José Silva-OliveiraAna Carolina de CarvalhoMatias Eliseo MelendezBruna Pereira SorrocheRenan de Jesus TeixeiraKatiane TostesEdenir Inez PalmeroRui Manuel Vieira ReisAndre Lopes CarvalhoPublished in: Head & neck (2023)
These findings hold promise for the development of more personalized and effective treatment approaches for HNSCC patients.